ArticlePharmaceuticals (Basel, Switzerland)2026
Hypophosphatemia as a Potential Class Effect of Histone Deacetylase Inhibitors: Evidence from Disproportionality Analysis and Mendelian Randomization Analysis of Drug Targets.
Ruiqi Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.